ALDH7A1 and chronic obstructive pulmonary disease: Theophylline was one of the early discovered agents having weak activity and no selectivity towards the different PDE subfamilies (as well as antagonist effects on A1 and A3 adenosine receptors), initially used in the clinics to treat asthma and COPD.